163 related articles for article (PubMed ID: 10378838)
1. Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution.
Davis KB; Slichter SJ; Corash L
Transfusion; 1999 Jun; 39(6):586-92. PubMed ID: 10378838
[TBL] [Abstract][Full Text] [Related]
2. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy of low and high dose prophylactic platelet transfusion therapy in thrombocytopenic haemato-oncology patients.
Dhiman Y; Hans R; Sharma RR; Malhotra P; Marwaha N
Transfus Apher Sci; 2020 Feb; 59(1):102610. PubMed ID: 31345687
[TBL] [Abstract][Full Text] [Related]
5. Intravascular and total body platelet equilibrium in healthy volunteers and in thrombocytopenic patients transfused with single donor platelets.
Brubaker DB; Marcus C; Holmes E
Am J Hematol; 1998 Jul; 58(3):165-76. PubMed ID: 9662266
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.
Slichter SJ; Davis K; Enright H; Braine H; Gernsheimer T; Kao KJ; Kickler T; Lee E; McFarland J; McCullough J; Rodey G; Schiffer CA; Woodson R
Blood; 2005 May; 105(10):4106-14. PubMed ID: 15692069
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of cross-match compatible platelets in multi transfused haemato-oncology patients refractory to platelet transfusion.
Chavan A; Sharma RR; Saikia B; Malhotra P; Prakash S; Hans R; Marwaha N
Transfus Apher Sci; 2019 Dec; 58(6):102657. PubMed ID: 31706911
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing 20-hour increments after platelet transfusion.
Bishop JF; Matthews JP; McGrath K; Yuen K; Wolf MM; Szer J
Transfusion; 1991 Jun; 31(5):392-6. PubMed ID: 2048176
[TBL] [Abstract][Full Text] [Related]
9. Platelet function testing to assess effectiveness of platelet transfusion therapy.
Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.
Hess JR; Trachtenberg FL; Assmann SF; Triulzi DJ; Kaufman RM; Strauss RG; Granger S; Slichter SJ
Vox Sang; 2016 Oct; 111(3):281-291. PubMed ID: 27185561
[TBL] [Abstract][Full Text] [Related]
11. Platelet Survival in Hematology Patients Assessed by the Corrected Count Increment and Other Formulas.
Jaime-Pérez JC; Vázquez-Hernández KE; Jiménez-Castillo RA; Fernández LT; Salazar-Riojas R; Gómez-Almaguer D
Am J Clin Pathol; 2018 Jul; 150(3):267-272. PubMed ID: 29982409
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of Factors Influencing Posttransfusion Effectiveness in 26045 Cases of Platelet Transfusion].
Chen LF; Pan JC; Feng Q; Luo YY; Yu Y; Zhuang Y; Li H; Feng YN; Wang DQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1081-6. PubMed ID: 26314450
[TBL] [Abstract][Full Text] [Related]
13. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
[TBL] [Abstract][Full Text] [Related]
14. Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation--a prospective analysis.
Ishida A; Handa M; Wakui M; Okamoto S; Kamakura M; Ikeda Y
Transfusion; 1998 Sep; 38(9):839-47. PubMed ID: 9738624
[TBL] [Abstract][Full Text] [Related]
15. Transfusion of platelet concentrates from pooled buffy-coats: comparison of bedside vs. prestorage leukofiltration.
Müller-Steinhardt M; Schlenke P; Wagner T; Klüter H
Transfus Med; 2000 Mar; 10(1):59-65. PubMed ID: 10760204
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
17. Design of clinical trials to evaluate the efficacy of platelet transfusion: the euroSPRITE trial for components treated with Helinx technology.
Cazenave JP; Davis K; Corash L
Semin Hematol; 2001 Oct; 38(4 Suppl 11):46-54. PubMed ID: 11727285
[TBL] [Abstract][Full Text] [Related]
18. Platelet corrected count increments by apheresis platform.
Tobian AA; King KE; Borge PD; Fuller AK; Uglik K; Ness PM
Transfusion; 2016 Oct; 56(10):2584-2586. PubMed ID: 27572682
[TBL] [Abstract][Full Text] [Related]
19. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
20. Incubation of platelet concentrates before transfusion does not improve posttransfusion recovery.
Hussein MA; Schiffer CA; Lee EJ
Transfusion; 1990 Oct; 30(8):701-3. PubMed ID: 2219256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
